|
June 2, 2021
|
Progenity Launches Strategic Transformation into Biotech Company, Eliminating Costs of Progenity Genetics Lab and Focusing on Robust, Innovative R&D Pipeline
|
|
May 26, 2021
|
Progenity Provides Results from Key Study for Its Targeted Therapeutics Program
|
|
May 25, 2021
|
Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
|
|
May 24, 2021
|
Progenity Announces Poster Presentations at Digestive Disease Week 2021
|
|
May 21, 2021
|
Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day – May 22nd
|
|
May 13, 2021
|
Progenity Provides Corporate Update and Reports First Quarter 2021 Financial Results
|
|
May 12, 2021
|
Progenity Provides Preliminary Results from Key Studies for its Targeted Therapeutics Program
|
|
May 11, 2021
|
Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD
|
|
May 6, 2021
|
Progenity to Report First Quarter 2021 Financial Results and Provide Corporate Update
|
|
May 5, 2021
|
Progenity Provides Key Update Regarding its Preecludia™ Test for Preeclampsia
|
